A 28-year-old woman with drug-susceptible pulmonary TB is on standard HRZE therapy. She presents with progressive bilateral foot pain, numbness, and tingling in a stocking-glove distribution after 3 months of treatment. Nerve conduction studies show slowing of conduction velocity in both lower limbs. Which investigation is most appropriate to confirm the diagnosis of isoniazid-induced peripheral neuropathy and assess severity?